Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a -4.752% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a FC(F)(F)c1ccc(CN2C[C@@H]3C(c4ccccc4)C4(c5cccnc5)CC3(C4)[C@H]2c2ccccc2)cc1
b CC1C(=O)N(Cc2cccc(F)c2)c2ccccc2N1C(=O)c1ccccc1
Answer: b. CC1C(=O)N(Cc2cccc(F)c2)c2ccccc2N1C(=O)c1ccccc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC1C(=O)N(Cc2cccc(F)c2)c2ccccc2N1C(=O)c1ccccc1
CC1C(=O)N(Cc2cccc(F)c2)c2ccccc2N1C(=O)c1ccccc1
4-benzoyl-1-[(3-fluorophenyl)methyl]-3-methyl-3H-quinoxalin-2-one